Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05834569
Other study ID # 2023GR0023
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date June 15, 2023
Est. completion date December 31, 2025

Study information

Verified date September 2023
Source Korea University Guro Hospital
Contact Heezoo KIM, MD, PhD
Phone 82-2-2626-1437
Email kimheezoo@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary aim of this interventional study is to investigate the impact of perioperative administration of Maxigesic (combination of acetaminophen and ibuprofen) on delirium after minimally invasive lung surgery in elderly patients. The Maxigesic group receives a total of 5 doses of Maxigesic (20mg/kg, maximum dose per serving: 1g) every 6 h from immediately after anesthesia induction. The control group receives the same volume of normal saline. Researchers compare the incidence and severity of postoperative delirium for 5 days after surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 176
Est. completion date December 31, 2025
Est. primary completion date December 1, 2025
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Patients aged 65 years or older undergoing minimally invasive lung lobectomy or segmentectomy Exclusion Criteria: - Hypersensitivity to the main ingredients and additives of Maxigesic - Hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) - Alcoholism / Alcohol intoxication - Severe hematological abnormalities - Bleeding tendency (e.g., Spontaneous bleeding) - Severe hepatic dysfunction (AST, AST =2.5 * upper normal limit(UNL) or Total bilirubin =3.0 mg/dl) - Severe renal dysfunction (eGFR <30 ml/min/1.73m2 or Dialysis) - Severe heart failure (Left ventricle ejection fraction <30%) - Uncontrolled hypertension(HTN) (Systolic blood pressure >180 mmHg) - Symptomatic asthma in need of treatment - Anticoagulants or antiplatelet agents are maintained for up to 5 days before surgery - Barbiturates or tricyclic antidepressants (TCAs) - High-dose methotrexate (MTX) for cancer treatment - Preoperative cognitive impairment, dementia, or delirium - Inability to understand the research and instructions for this study

Study Design


Intervention

Drug:
Acetaminophen and Ibuprofen
Patients in the Maxigesic group will be administered a total of 5 doses of the drug (20mg/kg, maximum dose per serving: 1g) every 6 h from immediately after anesthetic induction.
Normal saline
Patients in the control group will be administered equal amounts of normal saline at the same time points.

Locations

Country Name City State
Korea, Republic of Korea University Guro Hospital Seoul

Sponsors (2)

Lead Sponsor Collaborator
Korea University Guro Hospital Kyongbo Pharmaceutical Co.,Ltd

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of postoperative delirium(POD) Confusion assessment method(CAM)/Confusion Assessment Method for the ICU (CAM-ICU) or delirium record on electrical medical record(EMR) will be used for the evaluation of POD. From immediately after surgery to 5 days after surgery
Secondary Severity of POD CAM-S(severity) will be utilized to assess the severity of POD. (*CAM-S is measured on 0-7 (short form) and 0-19 (long form) scale, and the higher the score, the greater the POD severity.) From immediately after surgery to 5 days after surgery
Secondary Duration of POD CAM/CAM-ICU or delirium record on EMR will be used to estimate the duration of POD. From immediately after surgery to 5 days after surgery
Secondary Preoperative cognition Mini-mental state examination(MMSE) will be used to evaluate the participants' preoperative cognition. (*MMSE is measured on 0-30 scale, and the lower the score, the more cognitively impaired the patient is.) 1 day before surgery
Secondary Preoperative cognition Montreal cognitive assessment(MoCA) will be used to evaluate the participants' preoperative cognition. (*MoCA is measured on 0-30 scale, and the lower the score, the more cognitively impaired the patient is.) 1 day before surgery
Secondary Preoperative frailty Clinical frailty scale(CFS) will be utilized to assess the preoperative frailty (*CFS is used to determine comprehensive geriatric assessment. It is measured on 1-9 scale, and the higher the scale, the more frail the patient is.) 1 day before surgery
Secondary Postoperative pain Numerical rating scale (NRS) or Visual analogue scale (VAS) will be used to determine the postoperative pain severity (*NRS and VAS are measured on a 0-10 scale, and the higher the score, the more severe the patient's pain. If the patient can verbalize their pain, use the NRS; otherwise, use the VAS to assess pain). Immediately after surgery to postoperative 48 hours
Secondary Consumption of opioids Opioid consumption is measured by converting them into morphine equivalents. Immediately after surgery to postoperative 48 hours
Secondary Postoperative nausea, vomiting Nausea is measured by scoring on a scale of 0-10. The higher the score, the more severe the symptom. Whether the patients vomit or not is observed and recorded. Immediately after surgery to postoperative 48 hours
Secondary ICU stay Determine how many days the participant stays in the ICU. Immediately after surgery to ICU discharge(usually within about 5 days after surgery)
Secondary Hospital stay Determine how many days the participant stays in the hospital. Immediately after surgery to hospital discharge(usually within about 30 days after surgery)
Secondary Postoperative complications Investigate all kinds of complications that occur after surgery. Immediately after surgery to hospital discharge(usually within about 30 days after surgery)
Secondary Drug side effects Investigate complications suspected to be side effects caused by the study drug. Immediately after surgery to hospital discharge(usually within about 30 days after surgery)
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT05891873 - Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT06194474 - Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
Completed NCT03095417 - Improving the Recovery and Outcome Every Day After the ICU N/A
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Not yet recruiting NCT04846023 - Pediatric Delirium Screening in the PICU Via EEG N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Withdrawn NCT02673450 - PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
Recruiting NCT03256500 - Transcranial Direct Current Stimulation for the Treatment of Delirium N/A
Completed NCT02890927 - Geriatric-CO-mAnagement for Cardiology Patients in the Hospital N/A
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Recruiting NCT03165539 - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Completed NCT02554253 - The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction Phase 2
Completed NCT02518646 - DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models N/A
Recruiting NCT02305589 - The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium N/A
Completed NCT02628925 - Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale N/A